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Background: Surgical resection is the only hope for patients with cholangiocarcinoma (CC). This study is
designed to assess the impact of cirrhosis on the outcome of surgical management for CC.
Patient and methods: We retrospectively studied all patients who underwent surgical resection for hilar
CC. Group I (patients with cirrhotic liver) and Group II (patients with non-cirrhotic liver). Preoperative
demographic data, intra-operative data, and postoperative details were collected.
Results: Only 102/243 patients (41.9%) had cirrhotic liver. Caudate lobe resection was more frequently
performed in the non-cirrhotic group (P ¼ <0.001). There was no difference between both groups
regarding intraoperative blood loss and the need for blood transfusion. The median postoperative stay
was higher in the cirrhotic group (P ¼ 0.063). The incidence of early postoperative liver cell failure was
signiﬁcantly higher in the cirrhotic group (P ¼ <0.001). Cirrhosis was associated with signiﬁcantly lower
overall survival (P ¼ <0.001).
Conclusion: Patients with concomitant liver cirrhosis and hilar CC should not be precluded from surgical
resection and should be considered for resection at high volume centers with expertise available to
manage liver cirrhosis. The incidence of early postoperative liver cell failure was signiﬁcantly higher in
the cirrhotic group.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Extrahepatic cholangiocarcinoma (CC) is infrequently reported
with a background of liver cirrhosis [1]. However, the incidence of
intrahepatic CC associated with hepatitis C virus (HCV) induced
cirrhosis is estimated to be 0.3% per year [2]. The relation between
HCV induced cirrhosis and CC is still unclear and there are con-
ﬂicting results in the literature which mandates further studies [3].
Although multiple studies asserted the increased risk ofO-2957 in IHPBA 2014 world
elnakeebayman@gmail.com
by Elsevier Ltd. All rights reservedintrahepatic CC in patients with HCV liver cirrhosis, there is no
reported association between HCV cirrhosis and extrahepatic CC
[4].
Established risk factors for extrahepatic CC include primary
sclerosing cholangitis, parasitic infection, choledocholithiasis, and
toxins [5]. The presence of schistosomiasis, chronic typhoid infec-
tion, cholecystolithiasis together with environmental pollution
contribute to the high incidence of cholangiocarcinoma in Egypt
[6]. Egypt is also known for the highest worldwide prevalence of
HCV infection and its complications, especially liver cirrhosis [7].
This made the association between extrahepatic CC and HCV
induced cirrhosis a relatively common ﬁnding in our center.
Traditionally, cirrhosis has been considered as an absolute
contraindication to major abdominal operation. The hospital.
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patients undergoing any abdominal operation [1e6]. To our
knowledge, this is the ﬁrst study that exclusively examines the
impact of cirrhosis on surgical management of extrahepatic CC in
one of the hot spots of HCV induced cirrhosis in the world [6].
As surgical resection is the only hope of cure for patients with CC
[8], this study is designed to assess the impact of cirrhosis on the
outcome of surgical management for CC. It also helps to investigate
how the presence of cirrhosis can change the surgical decision.
2. Patients and methods
This is a retrospective study on 243 patients who underwent
surgical resection for pathologically proven hilar CC between
January 1995 and December 2010 in the Gastrointestinal Surgical
Center, Mansoura University, Egypt. Patient data were collected
from a prospectively maintained database on an internal web-
based registry system supplemented by paper records. Patients
were then divided into two groups according to the liver status:
cirrhotic and non cirrhotic patients. Cirrhosis was diagnosed by
liver biopsy. The extent of liver cirrhosis was estimated by the
modiﬁed ChildeTurcotteePugh (CTP) classiﬁcation [9].
2.1. Preoperative assessment
Preoperative evaluation of tumor extent was done by triphasic
abdominal computerized tomography (CT), and/or magnetic reso-
nance cholangiopancreatography (MRCP). Preoperative portal vein
embolization was not done in any case. Routine esophagogastro-
scopy was done for all cirrhotic patients for assessment and man-
agement of esophageal and gastric varices. Preoperative biliary
drainage was done in patients with clinical features of cholangitis.
Preoperative biliary drainage was achieved by ultrasound guided
(US) percutaneous transhepatic drainage (PTD) or by endoscopic
retrograde cholangiography (ERC) and stenting.
In this study, candidates for surgical management were patients
with resectable extrahepatic CC with CTP classes A and B (patient's
score less than 8). Patients were excluded from surgery when they
were CTP classes B (patient's score > 8), CTP class C, patients with
risk of bleeding esophageal or gastric varices and patients with
thrombosed portal vein.
2.2. Surgical procedure
Laparotomywas done through a bilateral subcostal incisionwith
an upward midline extension. Intraoperative US was done to assess
tumor extent, its relation to major vascular structures and to map
extent of liver resection. Liver resection was carried out using a
harmonic scalpel with or without intermittent inﬂow clamping
(Pringle's maneuver). A minor liver resection was deﬁned as
resection of three or fewer segments while major liver resection
was resection of four segments or more according to the Couinaud
nomenclature. All patients underwent concomitant extrahepatic
biliary resection and lymphadenectomy of loco-regional LNs.
Lymphadenectomy was carried out starting from the celeic trunk
upward toward the hilum to include all regional lymph nodes and
lymphatics with enbloc resection of the primary tumor. The
regional lymph nodes included the cystic duct, pericholedochal,
hilar, periportal, periduodenal, peripancreatic and celiac nodes.
2.3. Postoperative management
After surgery, all patients were admitted to the Intensive Care
Unit in the early post operative period and received standard post
operative care by the same surgical team thereafter.Liver functions were measured on the ﬁrst postoperative day,
postoperative day (POD) 3 and POD 5. Abdominal ultrasound was
done routinely for all patients, and repeated if we suspected
intraabdominal collection. US guided tubal drainage was done if
there was any abdominal collection.
Post hepatectomy liver cell failure (LCF) was deﬁned as an
increased international normalized ratio and concomitant
hyperbilirubinemia on or after the ﬁfth postoperative day [10].
We adopted the deﬁnition proposed by the International Study
Group for Liver Surgery for biliary leakage as “bilirubin concen-
tration in the drainage ﬂuid at least 3 times the serum bilirubin
concentration on or after postoperative day 3 or when there was a
need for radiologic or operative management of biliary collections
or bile peritonitis” [11]. Posthepatectomy hemorrhage was
deﬁned as a drop in hemoglobin level of more than 3 g/dl from
the post-operative baseline level and/or any post-operative
transfusion of packed red blood cells for a falling hemoglobin
and/or the need for radiological or surgical intervention to control
bleeding [12].
2.4. Immunohistochemistry
Parafﬁn-embedded sections from the tumors were deparafﬁ-
nized with xylene, followed by decreasing concentrations of
ethanol. Then, the sections were treated with 3% hydrogen
peroxide in methanol for 10 min to block endogenous peroxidase
activity. Slides were heated in vapor power using EDTA at pH 9.4 for
antigen retrieval. Sections thenwere incubated for 1 h at 37 Cwith
primary antibodies (CK7, CK19, EMA and Hep-par) from DAKO, CA,
USA. The sections were then incubated in an EnVision system
(DAKO, CA, USA) for 30 min at 37 C with washing in phosphate
buffered saline. Diaminobenzidine was used as the chromogen.
2.5. Follow up
Follow up was carried out at 1 month, 3 months and then every
6 months. Each visit included a clinical examination, routine lab-
oratory investigation (including complete blood picture, liver
function, blood sugar and tumor markers CEA, CA19-9), and
abdominal ultrasound and abdominal computed tomography (CT)
to search for recurrence after resection.
2.6. Data collection
Preoperative clinical data, intra-operative data, postoperative
course, postoperative complications, recurrence rate and survival
rate were collected.
2.7. Assessments
The primary outcome measure was Post hepatectomy liver cell
failure (LCF). Secondary outcomes analyzed included duration of
operation, amount of blood loss, blood transfusion, length of
postoperative stay, postoperative morbidity including (biliary
leakage, internal hemorrhage, liver cell failure, development of
ascitis, esophageal bleeding, PV thrombosis), hospital mortality
rate, recurrence rate and survival rate.
Statistical analysis of the data in this study was performed using
SPSS software, version 17 (Chicago, IL). Descriptive data were
expressed as means with standard deviation or medians with
ranges. Categorical variables were described using frequency dis-
tributions. Independent sample t-test was used to detect differ-
ences in the means of continuous variables and Chi-square test was
used in cases with low expected frequencies. Survival curves were
done using the KaplaneMeier method, and differences in survival
Table 1
Baseline characteristics.
Cirrhotic Non-cirrhotic p-value
Age 54 (48e62) 54 (48e60) 0.437
Sex 0.356
 Male 66 (64.7%) 83 (58.9%)
 Female 36 (35.3%) 58 (41.1%)
Pain 47 (46.1%) 38 (27%) 0.002
Jaundice 102 (100%) 140 (99.3%) 0.58
Weight loss 44 (43.1%) 67 (47.5%) 0.499
HCV 52 (51%) 49 (34.8%) 0.011
HBsAg 1 (1%) 3 (2.1%) 0.44
ERCP 15 (14.7%) 19 (13.5%) 0.785
PTD 33 (32.4%) 42 (29.8%) 0.669
Serum albumin 3.7 (3.4e4) 3.7 (3.5e4) 0.984
Total serum bilirubin 15.8 (9.9e20.5) 14 (6.2e21) 0.202
Serum alkaline phosphatase 25 [19e35] 23 (15e32.5) 0.042
SGOT 80 (61.8e100) 86 (59e118.5) 0.296
SGPT 65.5 (45e85) 80 (55e115.5) 0.003
Ca19-9 310 (163e600) 300 (159e507) 0.553
Serum AFP 2.9 [2e5] 2 (1.5e3.2) 0.057
CEA 4 [3e5] 3 [2e4] 0.019
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values < 0.05 were considered signiﬁcant.
3. Results
243 patients underwent surgical resection for pathologically
proven hilar cholangiocarcinoma. The tumor cells were positive for
CK7, CK19, and EMA, but negative for Hep-par, which supported the
diagnosis of cholangiocarcinoma (Fig 1). Liver cirrhosis was present
in 102 patients (41.9%) while 141 patients (57.1%) had non-cirrhotic
liver. There was no signiﬁcant difference between the cirrhotic and
non-cirrhotic groups regarding patient age, sex and preoperative
biliary drainage (Table 1).
The clinical presentation and preoperative liver function are
presented in table [1].
Intraoperative data are shown in Table 2.
Surgical resection in the cirrhotic group included left hepatec-
tomy in 36 patients (35.3%), right hepatectomy in 16 patients
(15.7%) and local resection of segment 4 in 50 patients (49%). In the
non-cirrhotic group, left hepatectomy was done in 78 patients
(55.3%), right hepatectomy in 39 patients (27.7%) and local resec-
tion of segment 4 in 24 patients (17%). The incidence of major
hepatectomy was signiﬁcantly higher in the non-cirrhotic group
(P ¼ 0.001). Also, caudate lobe resection was more frequently
performed in the non-cirrhotic group (P ¼ <0.001).
The postoperative data are shown in Table 3
Cirrhosis was associated with signiﬁcantly lower overall and
disease free survival (P ¼ <0.001) (Table 3, Fig. 2(a,b)).
4. Discussion
The adverse effect of liver cirrhosis on morbidity and mortality
following gastrointestinal surgery was reported in many studiesFig. 1. a) Cholangiocarcinoma with cirrhotic liver (H&Ex40). b) CK7: Diffuse positive cytop
membranous reaction (peroxidasex200) d) EMA (epithelial membrane antigen) Diffuse pos[13e17]. In the past, cirrhosis has been considered a contraindica-
tion to major gastrointestinal surgery and the hospital mortality
rates have been found to be 20% to 38% for cirrhotic patients un-
dergoing major abdominal operations [13e18]. Cirrhotic patients
are at an increased tendency of bleeding, sepsis, hepatic decom-
pensation including hepatic coma [14e16]. Now, major surgical
operations can safely be performed in cirrhotic patients with
improvement in preoperative care, surgical techniques with mini-
mal intraoperative bleeding and improvement in medical man-
agement [13e16].
No guideline has been issued for the management of resectable
hilar cholangiocarcinoma in cirrhotic patients. In the presence oflasmic reaction (peroxidasex200) c) CK19: Diffuse positive cytoplasmic reaction with
itive cytoplasmic reaction (peroxidasex200).
Table 2
Operative data.
Cirrhotic Non-cirrhotic p-value
BismutheCorlette classiﬁcation
Type I, II 50 (49%) 24 (17%)
Type IIIa 16 (15.7%) 39 (27.7%) 0.0001
Type IIIb 36 (35.3%) 78 (55.3%)
Type IV 0 0
Extent of resection
Localized 41 (40.2%) 29 (20.6%) 0.001
Major 61 (59.8%) 112 (79.4%)
Segment 1 resection 27 (26.5%) 75 (53.2%) <0.001
Median blood loss (ml) 700 (100e2500) 400 (50e2000) 0.0001
Blood transfusion
 <3 units 72 (70.6%) 101 (71.6%) 0.859
 3 units 30 (29.4%) 40 (28.4%)
Operative time (h) 3.86 (±1.4) 4.52 (±1.36) <0.001
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lection, good perioperative care, adequate counseling on operative
risk and good decision on extent of resection.
Although complete surgical resection remains the only hope for
cure for patients with hilar CC, it represents a major challenge to
hepatobiliary surgeons [19]. The tumor extent in the biliary system,
radial growth of the tumor and portal vein inﬁltration are the main
determinants of the extent of resection during surgery for hilar CC
[20]. In cirrhosis, the surgeon is concerned with the volume and
quality of the remnant liver after resection to avoid post-
hepatectomy LCF [21].
Surprisingly, preoperative liver functions were more affected in
the non-cirrhotic patients. Serum ALP and liver enzymes were
higher in the non-cirrhotic group but with signiﬁcant difference in
SGPT only. This can be explained by early detection of extrahepatic
CC in patients with cirrhosis during routine follow-up for cirrhosis
[2]. There was no signiﬁcant difference between the two groups
regarding serum albumin and prothrombin time despite there was
impaired synthetic function of the liver in cirrhosis. This justiﬁed
the exclusion of cirrhotic patients who were unﬁt for surgical
resection from the study population [2].Table 3
Postoperative data.
Cirrhotic Non-cirrhotic p-value
Hospital stay 12 (8e15.3) 12 (9e14) 0.063
Reexploration 8 (7.8%) 7 (5%) 0.357
Bile leak 41 (40.2%) 41 (29.1%) 0.07
Wound infection 20 (19.6%) 36 (25.5%) 0.279
Early liver cell failure 27 (26.5%) 12 (8.5%) <0.001
Collection 19 (18.6%) 25 (17.7%) 0.858
Bleeding and ﬁstula 8 (7.8%) 7 (5.0%) 0.357
Lymph node metastasis 52 (51%) 41 (29.1%) 0.001
Histological grade
 Well diff. 27 (26.5%) 69 (48.9%) <0.001
 Mod. diff. 36 (35.3%) 58 (41.1%)
 Poorly diff. 39 (38.2%) 14 (9.9%)
Safety margin
R0 37 (36.3%) 84 (59.6%) <0.001
R1 65 (63.7%) 57 (40.4%)
Operative mortality 4 (3.9%) 4 (2.8%) 0.452
Recurrence
 Hepatic 30 (29.4%) 29 (20.6%) 0.204
 Local 15 (14.7%) 18 (12.8%)
Late liver cell failure 31 (52.5%) 28 (43.8%) 0.33
Median survival (months) 16 22 0.001
1 year survival 66.4% 73.5%
3 years survival 17.2% 39%
5 years survival 0.5% 18.8%The role of preoperative biliary drainage in jaundiced patients
remains controversial. The presence of cholangitis mandate biliary
drainage, but there is no proof that routine biliary drainage in all
patients facilitates resection or reduces postoperative complication.
In most cases biliary drainage of a hemiliver is sufﬁcient since
drainage of 30% of the liver is enough to relieve jaundice. In con-
trary, biliary stents are associated with greater postoperative
infection [22e24]. In this study, 48 (47.06%) patients in the cirrhotic
group and 61 (43.3%) patients in the non-cirrhotic group required
unilateral biliary drainage.
Cirrhosis is expected to be associated with increased blood loss
and need for blood transfusion. In this study, there was no signif-
icant difference between the cirrhotic and no-cirrhotic groups
regarding blood loss and the need for transfusion. This can be
explained by the surgeon's preference to carry out local resection in
cirrhosis. Vitamin K injection and fresh frozen plasmawere given to
reduce bleeding tendency. Suture ligature was preferred rather
than cautery when possible.
The main concern to achieve successful surgical management of
hilar CC is to reduce the postoperative morbidity [25]. The most
devastating complication after surgery is post-hepatectomy LCF.
Although we adopted a more conservative approach regarding
surgical resection in cirrhotic patients, the incidence of post-
operative LCF was signiﬁcantly higher in cirrhotic patientsFig. 2. Actuarial survival (KaplaneMeier analysis) after resection of hilar chol-
angiocarcinoma: inﬂuence of Liver status (P ¼ 0.001).
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cirrhotic group. However, this did not reach statistical signiﬁcance.
R0 resection is one of the most important prognostic factors in
hilar CC [19,26]. Curative R0 resection is achieved in 60e85% of
patients with hilar CC according to recent reports [27,28]. In this
series, the overall rate of R0 resection in the two groups was 50%. A
positive resection margin was present in 63.7% of cirrhotic patients
when compared to 40.4% in non-cirrhotic patients (P ¼ <0.001).
This is can be attributed to either more aggressive tumors in
cirrhotic patients or to the surgeons' decision to avoid major
resection in cirrhotic livers.
According to previous reports, lymph node metastasis is present
in 20e50% of hilar CC [27,28]. Nodal metastasis is an independent
prognostic factor in hilar CC [8]. The overall rate of nodal involve-
ment in our experience with the two groups is 38%. Nodal
involvement was signiﬁcantly higher in cirrhotic patients (52%)
when compared with non-cirrhotic patients (29.1%) (P ¼ <0.001).
Metastatic disease to regional lymph nodes is not uncommon in
patients with hilar cholangiocarcinoma. There was a signiﬁcant
difference in survival based on nodal status [29]. Lymph node
metastasis beyond the hepatoduodenal ligament (celiac, mesentric
LN, or PALN) has a poor prognosis with a 5-year survival of 0e12%
[8,29]. Thus, it is considered a contraindication to resection
[8,29,30].
In the current study, caudate lobe resection was carried out in a
low proportion of patients (26.5% in cirrhotic and 53.2% in non-
cirrhotic patients). In the initial period of the study, caudate lobe
resection was performed only when inﬁltrated but now it is
resected routinely in all cases of hilar cholangiocarcinoma [31].
Surgeons tend to avoid caudate lobe resection in cirrhotic liver for
fear of postoperative liver cell failure and bleeding.
Hilar CC has a dismal prognosis even after R0 resection with an
estimated 5 year survival of about 20% [32,33]. Prognostic factors
that are established to affect survival are negative resectionmargin,
caudate lobe resection, lymph node metastasis and well differen-
tiated tumor grade [31,34,35]. Liver cirrhosis was found to affect
recurrence and survival in hilar CC patients [18]. In this study, Hilar
CC in cirrhosis tended to have worse oncological features and more
aggressive pattern in the form of R1 resection, lymph node
metastasis and poor tumor differentiation. This is similar to the
previous studies on intrahepatic CC in liver cirrhosis [2,36]. The
mechanism underlying this ﬁnding is still unclear. Tumor aggres-
sive pattern, avoidance of caudate lobe resection together with
poor hepatic reserve in cirrhosis can explain the worse 5-years
survival in cirrhotic patients (4%) in comparison to non-cirrhotic
patients (34.1%) (P ¼ <0.001).
One of the limitations of this study is the retrospective nature.
As mentioned before, we used a prospectively maintained database
for patients undergoing resection for CC and it had all the preop-
erative, intraoperative and postoperative data for every patients
(routine prospective practice). Another limitation of this study is
that the sample size was not calculated as this study was limited by
the duration of the study.
Conclusion: Patients with concomitant HCV induced liver
cirrhosis and hilar CC should not be precluded from surgical
resection. Surgical resection should be limited to patients with well
compensated chronic liver diseases. A thorough and precise pre-
operative evaluation is needed to assess tumor resectability before
subjecting patients to surgical exploration. An increased operative
risk should be considered during patient counseling. The extent of
surgical resection is dependent on the balance between radicality
and adequate hepatic reserve in cirrhotic patients. Surgical resec-
tion should be limited to experienced surgeons in high volume
centers where there is expertise in the management of liver
cirrhosis and postoperative complications.Ethical approval
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